The main purpose of the two open, non-comparative PMS studies reported here was to extend the knowledge base of the efficacy and tolerability of once-daily valsartan (trial 1) and the fixed ...

For the duration of trial 1, 61.0% of patients received valsartan alone, whereas 39.0% received additional antihypertensive agents at some point during the study. In trial 2, 75.8% of patients ...

Co-Diovan contains valsartan and hydrochlorothiazide. These medicines reduce blood pressure in two different ways. 1. Valsartan blocks the effect of angiotensin II, which is a substance in the ...